3) Onchocerciasis
نویسنده
چکیده
Historical view The parasite, Onchocerca volvulus, was first detected in a Ghanaian by a German missionary in 1890 and was nominated Filaria volvulus by Leuckart (1893). No pathogenicity of the parasite was found yet. In 1915, however, R. Robles reported the new distribution of this filarial parasite in Guatemala, Central America, after enormous parasitological, clinical and epidemiological studies of coastal erysipela (Erisipela de la costa). He clarified that O. volvulus caused ocular lesion and the denodulization improved the symptoms remarkably. This is the reason that the Government of Guatemala launched denodulization campaign in the endemic areas since 1935. Based on the specimens obtained by Robles and other information on vector blackfly species, Brumpt (1919) proposed O. caecutiens n.sp., while this new species was neglected by various parasitologists. Identification of vector insect blackfly by Blacklock in 1926 clarified transmission mechanism and encouraged vector control trials in Africa (Garnham and McMahon, 1947) in particular the Onchocerciasis Control Program (OCP) in late 1960s. A filaricide drug Diethylcarbamazine (DEC) showed curative effect, while it caused severe accessory reactions in the infected people as seen in Mazzotti reaction. Thus the mass treatment has been considered difficult before the appearance and registration of Ivermectin (Mectizan). Mass treatment by lvermectin based on the community based system recently accelerated African Program for Onchocerciasis Control (APOC) in Africa and Onchocerciasis Eradication Program of America (OEPA) in Central and South Americas in 1990s.
منابع مشابه
Molecular cloning and characterization of recombinant parasite antigens for immunodiagnosis of onchocerciasis.
Immunological cross-reactivity among nematodes has hampered the development of specific serodiagnostic assays for onchocerciasis. In the present study, an Onchocerca volvulus adult worm complementary DNA expression library was differentially screened with human sera from patients infected with O. volvulus and with an omnibus anti-nematode serum pool comprised of sera from patients infected with...
متن کاملHigh prevalence of epilepsy in onchocerciasis endemic regions in the Democratic Republic of the Congo
BACKGROUND An increased prevalence of epilepsy has been reported in many onchocerciasis endemic areas. The objective of this study was to determine the prevalence of epilepsy in onchocerciasis endemic areas in the Democratic Republic of the Congo (DRC) and investigate whether a higher annual intake of Ivermectin was associated with a lower prevalence of epilepsy. METHODOLOGY/PRINCIPLE FINDING...
متن کاملReport of the first international workshop on onchocerciasis-associated epilepsy
BACKGROUND Recently, several epidemiological studies performed in Onchocerca volvulus-endemic regions have suggested that onchocerciasis-associated epilepsy (OAE) may constitute an important but neglected public health problem in many countries where onchocerciasis is still endemic. MAIN TEXT On October 12-14th 2017, the first international workshop on onchocerciasis-associated epilepsy (OAE)...
متن کاملChanges in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate.
Eighteen patients, moderately to heavily infected with onchocerciasis, were treated with a standard course of diethylcarbamazine citrate (DEC-C). In addition to the well recognised systemic reactions to treatment, the following ocular changes occurred during therapy: (1) Transient pigment epithelial lesions were detected in 7 patients by fluorescein angiography. (2) Optic disc leakage, as shown...
متن کاملDrawing and interpreting data: Children's impressions of onchocerciasis and community-directed treatment with ivermectin (CDTI) in four onchocerciasis endemic countries in Africa
Although the depiction of a child leading a blind man is the most enduring image of onchocerciasis in Africa, research activities have hardly involved children. This paper aims at giving voice to children through drawings and their interpretation. The study was conducted in 2009 in Cameroon, Democratic Republic of Congo (DRC), Nigeria and Uganda. Children aged 6-16 years were asked to draw thei...
متن کاملThe Mectizan® Donation Program – highlights from 2005
Through the Mectizan Donation Program, Merck & Co., Inc. has donated Mectizan (ivermectin, MSD) for the treatment of onchocerciasis worldwide since 1987. Mectizan has also been donated for the elimination of lymphatic filariasis (LF) since 1998 in African countries and in Yemen where onchocerciasis and LF are co-endemic; for LF elimination programs, Mectizan is co-administered with albendazole,...
متن کامل